ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
| Project Title | Institution / Principal Investigator(s) | Grant Type |
Year |
State |
|---|---|---|---|---|
| Development of CAR-T therapy for Ewing sarcoma using zebrafish in vivo models | Children’s Hospital Los Angeles / James Amatruda, MD/PhD | Innovation Grants | 2024 | California |
| Utilizing chromatin directed inhibitors to regulate gene expression in Ewing sarcoma for therapeutic benefit | University of North Carolina / Justin Sperlazza, MD/PhD | Young Investigator Grants | 2024 | North Carolina |
| Vaccine-boosted CAR T cell therapy for high risk neuroblastoma | Children’s Hospital of Philadelphia / Timothy Spear, MD/PhD | Young Investigator Grants | 2024 | Pennsylvania |
| In vivo transdermal generation of CD33 CAR T-cells towards acute myeloid leukemia | University of California, Los Angeles / Ruby Sims, PhD | Young Investigator Grants | 2024 | California |
| Novel mechanisms and therapeutic targeting of chemoresistant rhabdomyosarcoma | Massachusetts General Hospital / Yueyang Wang, PhD | Young Investigator Grants | 2024 | Massachusetts |
| Therapeutic targeting of clonal hematopoiesis in RUNX1 mutant FPDMM | University of Pennsylvania / Robert Bowman, Ph.D. | RARE Grant Program (Research Accelerating RUNX1 Exploration) | 2024 | Pennsylvania |
| Unraveling GABAergic interneuron-like lineage in H3G34-mutant hemispheric high-grade gliomas: their impact on network formation and invasion | Dana-Farber Cancer Institute / Gustavo Alencastro Veiga Cruzeiro, PhD | Young Investigator Grants | 2024 | Massachusetts |
| Targeting the immunosuppressive effects of Myc-hyperactivation in high-risk osteosarcoma | Emory University / Jason Yustein, MD/PhD | Innovation Grants | 2024 | Georgia |
| Targeting and imaging immunometabolic vulnerabilities in diffuse midline glioma | The Regents of the University of California San Francisco / Pavithra Viswanath, PhD | Innovation Grants | 2024 | California |
| The role of tissue kallikrein 1 in hematopoietic stem cell transplant-associated thrombotic microangiopathy | Baylor College of Medicine / Sarah Sartain, MD | Innovation Grants | 2024 | Texas |